Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSorbic International Regulatory News (SORB)

  • There is currently no data for SORB

Interim Results

23 May 2008 07:36

RNS Number : 1016V
Ninety PLC
22 May 2008
 

Ninety Plc (the 'Company')

(AIM: NINE)

Unaudited Interim Results to 29 February 2008

Ninety Plc, a company established in order to acquire a controlling interest in a company, partnership or joint venture which will be located in the UK or Asia, is pleased to announce its unaudited interim results to 29 February 2008.

Website and contacts:

www.ninetyplc.co.uk

Angus Irens, Executive Director Tel: 020 3178 4506

Geoff Nash, FinnCap Tel: 020 7600 1658

Executive Director's Statement

I am pleased to be able to report on the Company's first trading period from incorporation on 15 June 2007 to 29 February 2008 (eight and a half months).

On 24 October 2007, the Company successfully placed 319,500,000 ordinary shares raising £3.1 million after issue expenses and was admitted to trading on AIM.

The issued share capital as at 29 February 2008 is 374,500,020 ordinary shares of 0.1p each.

Trading

As stated in the AIM admission document dated 19 October 2007, the Company has been established in order to acquire a controlling interest in a company, partnership or joint venture, still to be identified, located in the UK or Asia.

In this first period since incorporation, the Company has made a small loss after taxation of £17,152, which equates to a loss of 0.008 pence per share, and at 29 February 2008 holds cash balances of £3.06 million.

Investment Strategy and Progress to Date

Ninety Plc is the second investment vehicle listed by Albany Capital Plc. The first, Vestpa Plc, successfully completed the acquisition by way of reverse takeover of the China Food Company Plc in December 2007.

The Directors of Ninety Plc continue to evaluate a number of potential acquisitions, as outlined in the Company's admission document with the aim of completing a similar transaction to the one completed by Vestpa Plc.

 

I hope to be reporting to you shortly regarding developments.

Angus Irens

Executive Director

23 May 2008 

Unaudited condensed income statement for the period ended 29 February 2008

 
 
 
Unaudited
Eight and a half months period to
29 February
2008
£’000
 
 
 
Income
 
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Administrative expenses
 
 
 
 
(70)
 
 
 
 
 
 
 
 
 
 
 
 
Operating loss
 
 
 
 
(70)
 
 
 
 
 
 
 
 
 
 
 
 
Interest receivable
 
 
 
 
53
 
 
 
 
 
 
 
 
 
 
 
 
Loss on ordinary activities
before taxation
 
 
 
 
(17)
 
 
 
 
 
 
 
 
 
 
 
 
Taxation
 
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
Loss attributable to equity
Shareholders of the Company
 
 
 
 
 
(17)
 
 
 
 
 
 
 
 
 
 
 
 
Loss per ordinary share (pence)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Basic
 
 
 
 
(0.008)
 
 
 
 
- Diluted
 
 
 
 
(0.008)
 
 
 

 

Unaudited condensed balance sheet as at 29 February 2008

 

 
 
Note
Unaudited
29 February
2008
£’000
 
ASSETS
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
Trade and other receivables
 
 
 
 
31
 
Cash and cash equivalents
 
 
 
 
3,057
 
 
 
 
 
 
 
 
Total assets
 
 
 
 
3,088
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIABILITIES
 
 
 
 
 
 
Current liabilities
Trade and other payables
 
 
 
 
39
 
 
 
 
 
 
 
 
Total liabilities
 
 
 
 
39
 
 
 
 
 
 
 
 
EQUITY
 
 
 
 
 
 
Called up share capital
 
 
4
 
375
 
Share premium
 
 
 
 
2,659
 
Share-based payment reserve
 
 
5
 
32
 
Accumulated loss
 
 
 
 
(17)
 
Company’s shareholders’ equity
 
 
 
 
3,049
 
 
 
 
 
 
 
 
Total equity and liabilities
 
 
 
 
3,088
 
 
 
 
 
 
 
 

Unaudited condensed statement of changes in shareholders' equity for the period ended 29 February 2008 

 
Share
capital
 
Share
premium
 
Accumulated
loss
 
Share-based payment reserve
 
Total
 
£’000
 
£’000
 
£’000
 
£’000
 
£’000
 
 
 
 
 
 
 
 
 
 
Loss for the period
-
 
-
 
(17)
 
-
 
(17)
Issue of share capital
375
 
2,875
 
-
 
-
 
3,250
Share issue costs
-
 
(216)
 
-
 
32
 
(184)
At 29 February 2008
375
 
2,659
 
(17)
 
32
 
3,049
 
 
 
 
 
 
 
 
 
 

 

 

 

Unaudited condensed cash flow statement for the period ended 29 February 2008

 

 
 
Unaudited
Eight and a half months period to
29 February
2008
£’000
 
 
 
 
 
 
 
 
 
Net cash used in operating activities
 
 
 
(62)
 
 
 
 
 
 
 
 
 
Investing activities
 
 
 
 
 
 
Interest received
 
 
 
53
 
 
 
 
 
 
 
 
 
Net cash from investing activities
 
 
 
53
 
 
 
 
 
 
 
 
 
Financing activities
 
 
 
 
 
 
Proceeds from issue of ordinary share capital
 
 
 
3,250
 
 
Share issue costs
 
 
 
(184)
 
 
 
Net cash from financing activities
 
 
 
3,066
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net increase in cash and cash equivalents
 
 
 
3,057
 
 
 
Cash and cash equivalents at beginning of period
 
 
 
 
-
 
 
 
 
 
 
 
 
 
Cash and cash equivalents at end of period
 
 
 
3,057
 
 
 

 

 

Notes to the interim financial statements for the period ended 29 February 2008 

1. Basis of preparation

The interim financial statements for the eight and a half months ended 29 February 2008 has been prepared using accounting policies consistent with International Financial Reporting Standards and those set out in the Company's AIM Admission Document dated 19 October 2007and in accordance with International Accounting Standard (IAS) 34 Interim Financial Reporting.

2. Significant accounting policies

The interim financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Cash and cash equivalents

Cash and cash equivalents consist of cash on hand and balances with banks and other financial institutions and investments in money market instruments.

Financial instruments

Initial recognition and measurement

Financial instruments are recognised when the Company becomes party to the transaction. Initial measurement is at cost, which includes transaction cost, or fair value. Subsequent to initial recognition, these instruments are measured as follows:

Trade and other receivables 

Trade and other receivables are measured at amortised cost using the effective interest rate method.

Trade and other payables 

Trade and other payables are recognised at fair value, which is the agreed market price at the time the goods and services are provided. The Company accrues for all goods and services consumed but as yet unbilled at amounts representing management's best estimate of fair value.

Equity instruments

Equity instruments issued by the Company are recorded at the proceeds received, net of direct issue costs.

3.  Loss per share

The calculation of the loss per ordinary share is based on the loss on ordinary activities after taxation for the period and on the weighted average number of ordinary shares in issue during the period.

A reconciliation of the loss and weighted average number of shares used in the calculation are set out in the table below.

8.5 months ended 29 February 2008

Loss

£

Weighted

Average

Number of

Shares

Loss

per share

(pence)

Basic and diluted loss per ordinary share

(17,152)

205,639,016

(0.008)

4. Share capital

The Company was incorporated on 15 June 2007 with an authorised share capital of £50,000 divided into 5,000,000 ordinary shares of 1p each.

Following written resolutions dated 26 July 2007, the authorised share capital of the Company was increased to £500,000 and sub-divided so that the authorised share capital was 500,000,000 ordinary shares of 0.1p each.

On incorporation, the Company allotted and issued 20 ordinary shares of 0.1p each at par.

On 26 July 2007, the Company allotted and issued 55,000,000 ordinary shares of 0.1p each for a total cash consideration of £55,000.

On 24 October 2007, the Company allotted and issued 319,500,000 ordinary shares of 0.1p each for a total cash consideration after expenses of £3,066,000.

5. Share-based Payments

On the 19 October 2007, the Company entered into an option agreement with JM Finn Capital Markets Limited ("FinnCap") whereby the Company agreed to grant FinnCap an option to subscribe for shares in the Company as part consideration for corporate finance fees relating to the Company's admission to AIM. The option entitles FinnCap to subscribe for 5,500,000 Ordinary Shares of 0.1 pence at an exercise price of 1.0 pence per share. The Company has recognised a charge to the share premium account of £32,450 in respect of the share options granted to FinnCap in accordance with IFRS 2, Share-based Payment.

6. Ultimate Parent Undertaking

The Company's ultimate parent undertaking is Albany Capital Plc, a company incorporated in the United Kingdom. Albany Capital Plc owns 71.99 per cent of the Company's issued ordinary share capital.

7. Other information

The interim financial statements for the eight and a half months ended 29 February 2008 does not constitute statutory financial statements, and has not been audited by the Company's auditors.

The interim financial statements were approved by the Directors on 22 May 2008.

A copy of the interim financial statements will not be posted to shareholders but will be made available to the public at the Company's registered office, 17 Hanover SquareLondon W1S 1HU and on the Company's website.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ZLLFLVEBBBBF
12
Date   Source Headline
30th Jun 201512:40 pmRNSInterim Results
19th Jun 20151:35 pmRNSResignation of ISDX Corporate Adviser
16th Jun 20157:00 amRNSResignation of Nominated Adviser
7th May 201512:20 pmRNSResult of AGM
7th May 20157:00 amRNSUpdate on suspension
1st May 20157:00 amRNSSuspension of trading
30th Apr 20157:30 amRNSSuspension - Sorbic International Plc
22nd Apr 20157:16 amRNSBoard changes and update on fund's transfer
31st Mar 20157:00 amRNSNotice of AGM and Posting of R&As
19th Jan 20157:00 amRNSPreliminary Unaudited Results
19th Jan 20157:00 amRNSDirector Appointment
22nd Dec 20147:00 amRNSUpdate on Loan Notes and Notice of Results
10th Dec 20147:00 amRNSIssue of Equity Correction
9th Dec 20142:30 pmRNSIssue of Equity Correction
8th Dec 20147:00 amRNSIssue of Equity
10th Nov 20147:00 amRNSTrading Update
29th Aug 20147:00 amRNSRoll Over of Loan Notes
15th Jul 201410:45 amRNSResult of General Meeting
27th Jun 20143:15 pmRNSNotice of General Meeting
23rd Jun 20143:20 pmRNSFundraising of £0.25 million
23rd Jun 20143:15 pmRNSInterim Results
30th Apr 20147:00 amRNSTrading Update and Change of Broker
25th Feb 201411:30 amRNSResult of AGM
25th Feb 20147:00 amRNSAGM Statement
31st Jan 20147:00 amRNSTrading Update
16th Dec 20137:00 amRNSHolding(s) in Company
10th Dec 20137:00 amRNSPreliminary Unaudited Results
21st Oct 20137:00 amRNSTrading Update and Notice of Results
25th Sep 20139:10 amRNSNotification of Shareholding
11th Sep 20137:23 amRNSNotification of Shareholding
2nd Sep 20133:40 pmRNSChange of Registered Office
17th Jun 20137:00 amRNSInterim Results
30th May 20137:00 amRNSUpdate on Manufacturing Facilities
23rd Apr 201312:00 pmRNSResult of AGM
23rd Apr 20137:00 amRNSAGM Statement
3rd Apr 20137:00 amRNSBoard Change
25th Mar 20131:30 pmRNSFundraising of £0.7 million
26th Feb 201311:30 amRNSRoll over of Loan Notes and funding update
18th Jan 201311:00 amRNSNotification of Shareholding
31st Dec 20127:00 amRNSAgreement with APAC Chemical Corporation
20th Dec 20127:00 amRNSFurther update on Loan Notes
21st Nov 20127:00 amRNSPreliminary Results
4th Oct 20127:00 amRNSTR-1 Notification of Major Interest in Shares
24th Sep 20127:00 amRNSNotification of Shareholding
9th Aug 20127:00 amRNSUpdate on Ulanqab City manufacturing facility
17th Jul 20127:00 amRNSUpdate on Ulanqab City manufacturing facility
28th Jun 20127:00 amRNSInterim Results
28th Mar 201212:00 pmRNSResult of AGM
26th Mar 20123:00 pmRNSUpdate on Ulanqab City manufacturing facility
22nd Feb 201212:30 pmRNSPlacing to raise £0.7 million
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.